Contract 1333MG23PNCNS0010
The Queen'S University Of Belfast · Department Of Commerce · April 6, 2023
The Queen'S University Of Belfast was awarded a federal contract by Department Of Commerce (National Oceanic And Atmospheric Administration) on April 6, 2023 for $31,000 of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 13, 2026.
Contract details
- PIID
- 1333MG23PNCNS0010
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Chemicals
- First action
- April 6, 2023
- Latest action
- March 13, 2026
Description
IMMUNOREAGENTS FOR ALGAL TOXIN SENSORS
Modification timeline
-
March 13, 2026Mod P26001$-12.2K
-
April 6, 2023Base award$43.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Solomon Park Research Laboratories, Inc | Department Of Commerce | September 12, 2024 | $202.0K |
| Solomon Park Research Laboratories, Inc | Department Of Commerce | September 19, 2021 | $251.8K |
| Eckert & Ziegler Isotope Products, Inc. | Department Of Commerce | April 14, 2011 | $-267 |
| Resource Technology Corporation | Department Of Commerce | September 2, 2010 | $22.4K |
| Applied Biosystems, Llc | Department Of Commerce | March 15, 2010 | $0 |
| Dna Technology A/S | Department Of Commerce | January 29, 2009 | $0 |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 1333MG23PNCNS0010?
Contract 1333MG23PNCNS0010 is a federal contract awarded to The Queen'S University Of Belfast by Department Of Commerce on April 6, 2023 for $31,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 1333MG23PNCNS0010?
The Queen'S University Of Belfast won contract 1333MG23PNCNS0010 from Department Of Commerce.
How much is contract 1333MG23PNCNS0010 worth?
Contract 1333MG23PNCNS0010 has obligated $31,000 to date.